Merck uses the power of leading-edge science to save and improve lives around the world. For more than 130 years, they have brought hope to humanity through the development of important medicines and vaccines.
Merck’s vaccine portfolio includes a variety of vaccines that help prevent diseases at different stages of life, from infancy to adulthood. Some of the vaccines in Merck’s portfolio include:
- CAPVAXIVE: A single-dose vaccine that helps address Streptococcus pneumoniae
serotypes that cause adult invasive pneumococcal disease (IPD) - GARDASIL 9: A vaccine that helps prevent cervical, vulvar, vaginal, anal,
oropharyngeal and other head and neck cancers caused by human
papillomavirus (HPV) - M-M-R II: A vaccine that helps prevent measles, mumps and rubella
- PNEUMOVAX 23: A vaccine that helps prevent pneumococcal disease
- ProQuad: A vaccine that helps prevent measles, mumps, rubella and varicella
- RECOMBIVAX HB: A vaccine that helps prevent hepatitis B
- RotaTeq: A vaccine that helps prevent rotavirus
- VAQTA: A vaccine that helps prevent hepatitis A
- VARIVAX: A vaccine that helps prevent varicella